Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
8.36
+0.24 (2.89%)
At close: Jan 26, 2026, 4:00 PM EST
8.39
+0.04 (0.42%)
After-hours: Jan 26, 2026, 4:10 PM EST
Aligos Therapeutics Employees
Aligos Therapeutics had 70 employees as of December 31, 2024. The number of employees increased by 4 or 6.06% compared to the previous year.
Employees
70
Change (1Y)
4
Growth (1Y)
6.06%
Revenue / Employee
$37,800
Profits / Employee
-$1,235,171
Market Cap
51.41M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 70 | 4 | 6.06% |
| Dec 31, 2023 | 66 | -17 | -20.48% |
| Dec 31, 2022 | 83 | -10 | -10.75% |
| Dec 31, 2021 | 93 | 19 | 25.68% |
| Dec 31, 2020 | 74 | 13 | 21.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Q32 Bio | 26 |
| PDS Biotechnology | 24 |
| NeurAxis | 21 |
| Plus Therapeutics | 21 |
| iBio, Inc. | 20 |
| ABVC BioPharma | 19 |
| Instil Bio | 14 |
| OS Therapies | 5 |
ALGS News
- 5 days ago - Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates - GlobeNewsWire
- 6 weeks ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Aligos Therapeutics Presents Positive Data at HEP-DART 2025 - GlobeNewsWire
- 2 months ago - Aligos Therapeutics, Inc. (ALGS) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025 - GlobeNewsWire
- 2 months ago - Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Aligos Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire